Meteora Capital »

Phoenix Biotech Acquisition Class A shares owned by Meteora Capital

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Meteora Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.8M 170k 10.84
2023-06-30 $1.7M 152k 10.90
2023-03-31 $2.2M 205k 10.68
2022-12-31 $1.7M 169k 10.27
2022-09-30 $1.7M 165k 10.09

More positions owned by Meteora Capital

Churchill Capital Corp Vii Com Cl A (CVII)
Altc Acquisition Corp Com Cl A (ALCC)
Ares Acquisition Corporation Com Cl A
Graf Acquisition Corp Iv
Churchill Capital Corp Vi Com Cl A
Roadzen Ord Shs (RDZN)
L Catterton Asia Acquisition Class A Ord Shs
Churchill Capital Corp V Com Cl A
Zalatoris Acquisition Corp Com Cl A (TCOA)
Viveon Health Acquisition Common Stock (VHAQ)
Pyrophyte Acquisition Corp Cl A Ord Shs (PHYT)
Slam Corp Cl A Shs (SLAM)
Flame Acquisition Corp Com Cl A
Leo Hldgs Corp Ii Com Cl A
Ocean Biomedical (OCEA)

View all positions for Meteora Capital

Top funds holding Phoenix Biotech Acquisition Class A

Cantor Fitzgerald, L. P.
Walleye Trading Advisors
Berkley W R
Walleye Trading
FNY Investment Advisers
Kestra Private Wealth Services
PenderFund Capital Management

View all funds holding Phoenix Biotech Acquisition Class A